CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 65,675	$ 74,103
Accounts receivable, net	2,434	3,543
Other current assets	5,122	5,639
Total current assets	73,231	83,285
Property and equipment, net	2,299	2,407
Intangible assets, net	30,740	30,793
Goodwill	13,074	13,074
Other assets	1,693	1,692
Total assets	121,037	131,251
Current liabilities:
Accounts payable	1,500	332
Accrued expenses	9,742	9,212
Other current liabilities	126	185
Total current liabilities	11,368	9,729
Contingent consideration liability	19,000	18,800
Deferred tax liability	11,199	11,199
Other liabilities	975	862
Total liabilities	$ 42,542	$ 40,590
Commitments and Contingencies
Stockholders' equity:
Preferred stock, $0.001 par value; Authorized - 20,000 shares; issued and outstanding - none	$ 0	$ 0
Common stock, $0.0013 par value; Authorized - 160,000 shares; issued - 70,146 shares in 2016 and 2015	91	91
Additional paid-in capital	595,087	594,511
Treasury stock at cost, 200 shares of common stock	(2,741)	(2,741)
Accumulated other comprehensive loss	(92)	(26)
Accumulated deficit	(514,034)	(501,379)
Total Progenics stockholders' equity	78,311	90,456
Noncontrolling interests	184	205
Total stockholders' equity	78,495	90,661
Total liabilities and stockholders' equity	$ 121,037	$ 131,251